BridgeBio Pharma, Inc. Liquidation Value
BBIO
Other
Cash & Equivalents
$570.12M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $570.12M
Total Obligations: -$2.31B
$-1.74B
Per share: $-8.91
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $570.12M
AR: $139.44M
Total Obligations: -$2.31B
$-1.60B
Per share: $-8.19
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $570.12M
AR: $139.44M
Inventory: $26.75M
Total Obligations: -$2.31B
$-1.57B
Per share: $-8.06
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-1.74B | $-8.91 |
| Liquid Liquidation Value | $-1.60B | $-8.19 |
| Operating Liquidation Value | $-1.57B | $-8.06 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $570.12M |
| Accounts Receivable | $139.44M |
| Inventory | $26.75M |
| Current Liabilities | $287.97M |
| Long-term Debt | $2.01B |
| Op. Lease Liability | $10.00M |
| Finance Lease | N/A |
| Shares Outstanding | 194.8M |
Explore all 246 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $570.12M | $139.44M | $26.75M | $36.23M | $287.97M | $2.01B | $10.00M | N/A |
| 2025-09-30 | $642.95M | $116.52M | $24.53M | $18.70M | $216.60M | $2.01B | $8.72M | N/A |
| 2025-06-30 | $748.95M | $76.87M | $18.28M | $26.13M | $175.85M | $0 | $8.81M | N/A |
| 2025-03-31 | $540.60M | $115.27M | $3.95M | $27.52M | $152.10M | $0 | $10.12M | N/A |
▼ Community Notes